IV-361

Modify Date: 2024-07-09 23:54:49

IV-361 structure	Common Name	IV-361
	CAS Number	2055741-39-2	Molecular Weight	457.62
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₃H₃₂FN₅O₂Si	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of IV-361

IV-361 is an orally active and selective CDK7 inhibitor (Ki≤50 nM). IV-361 has anti-cancer activity (US20190256531A1)[1].

Name	IV-361

Description	IV-361 is an orally active and selective CDK7 inhibitor (Ki≤50 nM). IV-361 has anti-cancer activity (US20190256531A1)[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> CDK
Target	CDK7:≤50 nM (Ki) CDK2:≥1000 nM (Ki)
In Vitro	IV-361 has less inhibition on CDK2 (Ki≥1000 nM) or PLK1 (Ki≥5000 nM)[1]. IV-361 exhibits excellent IL-2 and IL-17 production inhibitory activity (all IC50≤100 nM) in periphery blood mononuclear cell (PBMC)[1]. IV-361 exhibits excellent HCT-116 cell growth inhibitory activity (GI50≤100 nM)[1].
In Vivo	IV-361 (25 mg/kg/day; orally) exhibits 46% or more rate of suppression of tumor volume in female BALB nude mice with HCT-116[1].
References	[1]. Noriaki Iwase, et al. Substituted dihydropyrrolopyrazole derivative. US20190256531A1.

Molecular Formula	C₂₃H₃₂FN₅O₂Si
Molecular Weight	457.62

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Shanghai Nianxing Industrial Co., Ltd
China
Product Name: IV-361
Price: Check
Purity: 98.0%
Delivery: 10 Day
Contact: Yang
Email: sales@echemcloud.com

Get all suppliers and price by the below link:

IV-361 suppliers